Form 483

Xoran Technologies, LLC Form 483, 2010-10-14

FDA issued a Form 483 to Xoran Technologies, LLC on 2010-10-14 with 8 public-safe observations.

483· Form 483 issued8 observations

Xoran Technologies, LLC · Ann Arbor, United States · Issued October 14, 2010

Overview

  • 8 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

14 Oct 2010
21 CFR 803.17

Lack of Written MDR Procedures

Cited by Gary D Urbiel Goldner

14 Oct 2010
21 CFR 806.10(a)(1)

Report of risk to health

Cited by Gary D Urbiel Goldner

14 Oct 2010
21 CFR 820.20(a)

Management ensuring quality policy is understood

Cited by Gary D Urbiel Goldner

14 Oct 2010
21 CFR 820.22

Quality audits - Lack of or inadequate procedures

Cited by Gary D Urbiel Goldner

14 Oct 2010
21 CFR 820.50(a)

Evaluation of suppliers, contractors, etc., requirements

Cited by Gary D Urbiel Goldner

Inspected site

XTXoran Technologies, LLCAnn Arbor, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1003.10(a)Cited across public-safe Form 483 observations1x
21 CFR 803.17Cited across public-safe Form 483 observations1x
21 CFR 806.10(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.198(b)Cited across public-safe Form 483 observations1x
21 CFR 820.20(a)Cited across public-safe Form 483 observations1x
21 CFR 820.22Cited across public-safe Form 483 observations1x
21 CFR 820.50(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 8 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere